Pioneering breakthrough in treatment of ‘devastating’ neurological disorder

IntraBio Inc has announced positive data from its multinational clinical trial of IB1001 for the treatment of GM2 Gangliosidosis (Tay-Sachs and Sandhoff disease). IB1001 demonstrated a statistically significant and clinically meaningful improvement in symptoms, functioning,...

Covid portal start-up exceeds 1 million tests and creates offshoot venture

As the UK continues learning how to live with the pandemic, some key questions remain. Chiefly, how will the NHS grapple with the huge diagnosis and treatment backlog that has built up, and will...

Cleaning breakthrough for listeria elimination

All traces of listeria spp in a highly sensitive food production environment have been successfully eliminated in a breakthrough pilot. The 11-week proof of concept saw Bio-Fence antimicrobial coatings applied to the floor and lower...

AI could improve diagnosis for over 100,000 prostate patients in UK

The use of AI to identify prostate cancer is currently being validated in the first retrospective study of its kind in the UK. Real-world data from hospitals and scanner types is being scrutinised, to show...

Advances in longitudinal RWD and genomics access for drug development in Africa

A new partnership aims to build the largest integrated clinical and genomics data biobank in Africa, representing a major boost for RWD research across the continent. The collaboration is between BC Platforms (BCP), a global...

Lung cancer treatment is a UK first

A grandfather has become the UK’s first lung cancer patient to benefit from a state-of-art radiotherapy treatment at The Christie NHS Foundation Trust. Barry Staniforth, 81, was treated using the Elekta MR-guided linear accelerator (MR-linac)...

Novel mechanism links IBD genetic defect to gut leakiness

A study into ‘leaky gut’ is the first to show how a disease mutation increases the risk of developing Inflammatory Bowel Disease (IBD). Researchers led by a biomedical scientist at the University of California, Riverside,...

New approach will help identify drugs that can ‘glue’ proteins together

A new screening method that can test the effectiveness of therapeutic molecules designed to ‘glue’ proteins together in the body has been developed by researchers at the University of Birmingham and the University of...

Protecting Digital Medtech Innovation

For many years the medical technology (medtech) sector has been at the forefront of innovation and the Covid-19 pandemic has not slowed it down, with new technology quickly being developed to test for, prevent...

Antimicrobial resistance ‘arms race’ heats up

An advanced interventional microbiomics company, which is developing non-antibiotic methods for the control of multiple-drug resistant superbugs and other infectious disease, is stepping up development of a cure for antibiotic resistant bacteria. BioPlx has set...

Breakthrough on horizon for superior bovine mastitis cure

Advanced studies into adjunct therapy in bovine mastitis are set to start. The condition is a significant economic and animal welfare issue for global dairy farmers, and this study, by Anifera, will build on promising...

Large-scale drug analysis reveals potential new COVID-19 antivirals

Researchers at the Francis Crick Institute and University of Dundee have screened thousands of drug and chemical molecules and identified a range of potential antivirals that could be developed into new treatments for COVID-19...

Artificial heart is successfully implanted

A bioprosthetic artificial heart has been implanted in a critically ill patient for only the third time ever in a commercial setting. The Aeson® device – heralded as the world’s most advanced total artificial heart...

Taster webinar announced ahead of first-ever approved qualification in the Management of Adaptation to...

Free registration: https://bookwhen.com/resiliencetoclimatechange/e/ev-szx9-20210930110000 Date & Time: Thursday 30 September, 11AM-12PM Ahead of the first delivery of the new Level 5 Certificate in the Management of Adaptation to Climate Change, the first-ever approved professional qualification in this...

Connect 2 Cleanrooms delivers solid-state battery production cleanroom for Ilika

Connect 2 Cleanrooms Ltd (C2C) has completed a new 340m2 cleanroom facility for Ilika PLC at its 1600m2 Stereax—millimetre-scale solid-state batteries—manufacturing facility. The cleanroom is a key element of Ilika’s new facility as it scales up Stereax, to become the first volume manufacturer...

Creating a repeatable environment for micro moulding

For injection moulders, upgrading plastics manufacturing with a cleanroom to gain access to medical markets is a common move and a natural progression pathway. Over the years, Connect 2 Cleanrooms (C2C) has provided modular...